Nuvesa Pharma Private Limited - Company Profile

It is a business services private limited company based in Panchkula, Haryana, India, established in 2024.
2024 Panchkula, Haryana, India Active
Last Updated:
Access Report
About Nuvesa Pharma Private Limited

Nuvesa Pharma Private Limited, a active private limited company, was established on 05 June 2024 in Panchkula, Haryana, India. it holds CIN: U46497HR2024PTC122276. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sanjeev Kumar (Director), Neetu Saini (Director), Aayush Wadhwa (Director). It holds ₹2.50 M open charges and no settled loans. It is based at Plot No 138, Industrial Area Phase 2, Panchkula, Haryana, 134113.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497HR2024PTC122276

  • Registration Number

    122276

  • Incorporation Date

    05 June 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 8 Months
  • Open Charges ₹ 2.50 M
Company report

Nuvesa Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nuvesa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nuvesa Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjeev Kumar Director 05 Jun 2024 Current
Neetu Saini Director 05 Jun 2024 Current
Aayush Wadhwa Director 11 Sep 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nuvesa Pharma.

Enhance accessibility to Nuvesa Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nuvesa Pharma revenue growth over time
Nuvesa Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nuvesa Pharma?

Unlock access to Nuvesa Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
30 Jul 2024 State Bank Of India ₹2.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Nuvesa Pharma?

Unlock and access historical data on people associated with Nuvesa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nuvesa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuvesa Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nuvesa Pharma
Recent Activity within the Organization
  • Director Appointment

    Aayush Wadhwa was appointed as a Director was appointed as a Director on 11 Sep 2025 & has been associated with this company since 5 months 2 days . was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 2.50 M with Charge ID 100976502 was registered on 30 Jul 2024. was documented.

  • Director Appointment

    Sanjeev Kumar was appointed as a Director was appointed as a Director on 05 Jun 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Neetu Saini was appointed as a Director was appointed as a Director on 05 Jun 2024 & has been associated with this company since 1 year 8 months . was documented.

  • Company Incorporation

    The activity Nuvesa Pharma Private Limited was registered on 05 Jun 2024 with Roc Delhi & aged 1 year 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nuvesa Pharma Private Limited?

The CIN of Nuvesa Pharma Private Limited is U46497HR2024PTC122276.

Where is Nuvesa Pharma Private Limited headquartered?

Nuvesa Pharma Private Limited is headquartered at Plot No 138, Industrial Area Phase 2, Panchkula, Haryana, 134113.

When was Nuvesa Pharma Private Limited incorporated?

Nuvesa Pharma Private Limited was incorporated on 05 June 2024.

Who are the current directors of Nuvesa Pharma Private Limited?

The current directors of Nuvesa Pharma Private Limited are

Is Nuvesa Pharma Private Limited a listed company?

Nuvesa Pharma Private Limited is unlisted.

What is the capital structure of Nuvesa Pharma Private Limited?

The authorized capital of Nuvesa Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available